Coronary artery disease in 116 kindred with familial type II hyperlipoproteinemia. 1974

N J Stone, and R I Levy, and D S Fredrickson, and J Verter

UI MeSH Term Description Entries
D006949 Hyperlipidemias Conditions with excess LIPIDS in the blood. Hyperlipemia,Hyperlipidemia,Lipemia,Lipidemia,Hyperlipemias,Lipemias,Lipidemias
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008074 Lipoproteins Lipid-protein complexes involved in the transportation and metabolism of lipids in the body. They are spherical particles consisting of a hydrophobic core of TRIGLYCERIDES and CHOLESTEROL ESTERS surrounded by a layer of hydrophilic free CHOLESTEROL; PHOSPHOLIPIDS; and APOLIPOPROTEINS. Lipoproteins are classified by their varying buoyant density and sizes. Circulating Lipoproteins,Lipoprotein,Lipoproteins, Circulating
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D011336 Probability The study of chance processes or the relative frequency characterizing a chance process. Probabilities
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D005260 Female Females

Related Publications

N J Stone, and R I Levy, and D S Fredrickson, and J Verter
August 1986, Japanese journal of medicine,
N J Stone, and R I Levy, and D S Fredrickson, and J Verter
April 1971, Clinical science,
N J Stone, and R I Levy, and D S Fredrickson, and J Verter
September 1976, Metabolism: clinical and experimental,
N J Stone, and R I Levy, and D S Fredrickson, and J Verter
January 2007, Cardiology journal,
N J Stone, and R I Levy, and D S Fredrickson, and J Verter
May 1992, Klinische Monatsblatter fur Augenheilkunde,
N J Stone, and R I Levy, and D S Fredrickson, and J Verter
November 1977, Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
N J Stone, and R I Levy, and D S Fredrickson, and J Verter
February 1976, Pediatrics,
N J Stone, and R I Levy, and D S Fredrickson, and J Verter
July 1974, American journal of diseases of children (1960),
N J Stone, and R I Levy, and D S Fredrickson, and J Verter
January 1973, Nutrition and metabolism,
Copied contents to your clipboard!